These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10387954)
41. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
43. Gamma irradiation effects on stability of poly(lactide-co-glycolide) microspheres containing clonazepam. Montanari L; Cilurzo F; Valvo L; Faucitano A; Buttafava A; Groppo A; Genta I; Conti B J Control Release; 2001 Aug; 75(3):317-30. PubMed ID: 11489319 [TBL] [Abstract][Full Text] [Related]
44. Extended release peptide delivery systems through the use of PLGA microsphere combinations. Burton KW; Shameem M; Thanoo BC; DeLuca PP J Biomater Sci Polym Ed; 2000; 11(7):715-29. PubMed ID: 11011769 [TBL] [Abstract][Full Text] [Related]
45. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858 [TBL] [Abstract][Full Text] [Related]
46. In vitro and in vivo evaluation of thyrotrophin releasing hormone release from copoly(dl-lactic/glycolic acid) microspheres. Heya T; Okada H; Ogawa Y; Toguchi H J Pharm Sci; 1994 May; 83(5):636-40. PubMed ID: 8071811 [TBL] [Abstract][Full Text] [Related]
47. Preparation and in vivo evaluation of huperzine A-loaded PLGA microspheres. Fu XD; Gao YL; Ping QN; Ren T Arch Pharm Res; 2005 Sep; 28(9):1092-6. PubMed ID: 16212243 [TBL] [Abstract][Full Text] [Related]
48. Effect of lecithin and MgCO3 as additives on the enzymatic activity of carbonic anhydrase encapsulated in poly(lactide-co-glycolide) (PLGA) microspheres. Sandor M; Riechel A; Kaplan I; Mathiowitz E Biochim Biophys Acta; 2002 Feb; 1570(1):63-74. PubMed ID: 11960690 [TBL] [Abstract][Full Text] [Related]
49. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
50. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist. Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531 [TBL] [Abstract][Full Text] [Related]
51. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP Pharm Res; 1999 Apr; 16(4):509-13. PubMed ID: 10227704 [TBL] [Abstract][Full Text] [Related]
52. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277 [TBL] [Abstract][Full Text] [Related]
53. In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems. Chen S; Singh J Pharm Dev Technol; 2005; 10(2):319-25. PubMed ID: 15926681 [TBL] [Abstract][Full Text] [Related]
54. Effect of gamma-irradiation on peptide-containing hydrophilic poly (d,l-lactide-co-glycolide) microspheres. Shameem M; Lee H; Burton K; Thanoo BC; Deluca PP PDA J Pharm Sci Technol; 1999; 53(6):309-13. PubMed ID: 10754729 [TBL] [Abstract][Full Text] [Related]
55. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice. Jung T; Koneberg R; Hungerer KD; Kissel T Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439 [TBL] [Abstract][Full Text] [Related]
56. Aqueous N,N-diethylnicotinamide (DENA) solution as a medium for accelerated release study of paclitaxel. Baek N; Lee J; Park K J Biomater Sci Polym Ed; 2004; 15(4):527-42. PubMed ID: 15212332 [TBL] [Abstract][Full Text] [Related]
57. Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres. Diwan M; Park TG Int J Pharm; 2003 Feb; 252(1-2):111-22. PubMed ID: 12550786 [TBL] [Abstract][Full Text] [Related]
58. [Preparation of PLGA microspheres encapsulating highly concentrated glycyrrhizin and the bile elimination of glycyrrhizin after subcutaneous administration in rats]. Ohyanagi K; Shintani K; Koga K Yakugaku Zasshi; 2010 Jan; 130(1):103-11. PubMed ID: 20046073 [TBL] [Abstract][Full Text] [Related]
59. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity. Na DH; Lee JE; Jang SW; Lee KC AAPS PharmSciTech; 2007 Jun; 8(2):Article 43. PubMed ID: 17622118 [TBL] [Abstract][Full Text] [Related]
60. Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. Choi HS; Seo SA; Khang G; Rhee JM; Lee HB Int J Pharm; 2002 Mar; 234(1-2):195-203. PubMed ID: 11839450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]